SEC 13F Intelligence

Mraz, Amerine & Associates, Inc. / JNJ

Mraz, Amerine & Associates, Inc.’s Johnson & Johnson Position

Does Mraz, Amerine & Associates, Inc. own Johnson & Johnson (JNJ)? Yes — 28.3K shares worth $7M (+1.02% of its 13F portfolio) as of Q1 2026, down from 28.3K shares the prior filed quarter.

Position Value
$7M
Q1 2026
Shares
28.3K
% of Portfolio
+1.02%
Quarters Held
30
currently held

Position History JNJ

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $3MQ4 ’19: $3MQ4 ’19Q1 ’20: $3MQ2 ’20: $3MQ3 ’20: $3MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $3MQ4 ’21: $3MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ3 ’22: $3MQ4 ’22: $3MQ4 ’22Q1 ’23: $3MQ2 ’23: $3MQ3 ’23: $3MQ4 ’23: $3MQ4 ’23Q1 ’24: $3MQ2 ’24: $3MQ3 ’24: $3MQ4 ’24: $3MQ4 ’24Q1 ’25: $4MQ2 ’25: $4MQ3 ’25: $5MQ4 ’25: $6MQ4 ’25Q1 ’26: $7Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202628.3K$7M+1.02%
Q4 202528.3K$6M+0.87%
Q3 202528.5K$5M+0.82%
Q2 202524.2K$4M+0.68%
Q1 202524.2K$4M+0.68%
Q4 202424.1K$3M+0.62%
Q3 202417.4K$3M+0.51%
Q2 202417.4K$3M+0.52%
Q1 202417.8K$3M+0.53%
Q4 202317.8K$3M+0.58%
Q3 202317.8K$3M+0.63%
Q2 202318.0K$3M+0.70%
Q1 202318.4K$3M+0.70%
Q4 202218.6K$3M+0.78%
Q3 202218.7K$3M+0.82%
Q2 202218.7K$3M+0.85%
Q1 202218.9K$3M+0.80%
Q4 202118.9K$3M+0.83%
Q3 202119.1K$3M+0.84%
Q2 202119.3K$3M+0.86%
Q1 202119.9K$3M+0.95%
Q4 202019.9K$3M+1.04%
Q3 202021.1K$3M+1.17%
Q2 202021.3K$3M+1.11%
Q1 202021.8K$3M+1.12%
Q4 201922.0K$3M+0.91%
Q3 201922.0K$3M+0.84%
Q2 201922.0K$3M+0.91%
Q1 201922.6K$3M+0.98%
Q4 201824.3K$3M+1.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mraz, Amerine & Associates, Inc.’s full portfolio or all institutional holders of JNJ.